For Investors
Dr. Robert FosterExecutive Chairman & Founder |
|
 |
|
| "Isotechnika is committed to creating long-term value for its shareholders. Our world-class scientific expertise and sharp focus in immunosuppression will ensure that the company attains its goal of being a leader in transplantation and autoimmune disease treatment." | |
Robert T. Foster, Ph. D. |
|
The information posted was accurate at the time of posting, but may be superseded by subsequent disclosures.
Last updated October 1, 2007